Yingqi Liu
- Molecular Biology
- Cancer Research top 10%
- Biomedical Engineering
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Menghuan LiZhong LuoKaiyong CaiYan HuXuan WangYuanyuan ZhaoChencheng XueLei Shi
- Topics
- RNA modifications and cancer (6 papers)Nanoplatforms for cancer theranostics (5 papers)interferon and immune responses (4 papers)
In The Last Decade
Yingqi Liu
67 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Molecular Biology 600
- Cancer Research 264
- Biomedical Engineering 223
- Immunology 220
- Pulmonary and Respiratory Medicine 207
Countries citing papers authored by Yingqi Liu
This map shows the geographic impact of Yingqi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqi Liu more than expected).
Fields of papers citing papers by Yingqi Liu
This network shows the impact of papers produced by Yingqi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqi Liu. The network helps show where Yingqi Liu may publish in the future.
Co-authorship network of co-authors of Yingqi Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Yingqi Liu. A scholar is included among the top collaborators of Yingqi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqi Liu. Yingqi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | Exosomal miR-302b rejuvenates aging mice by reversing the proliferative arrest of senescent cellsbreakdown → | 34 |
| 6 | 8 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 13 | |
| 11 | 3 | |
| 12 | 7 | |
| 13 | 5 | |
| 14 | 71 | |
| 15 | 17 | |
| 16 | 40 | |
| 17 | 12 | |
| 18 | 30 | |
| 19 | 71 | |
| 20 | 99 |
About Yingqi Liu
Yingqi Liu is a scholar working on Business and International Management, Cancer Research and Toxicology, having authored 73 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Nanoplatforms for cancer theranostics (5 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Cancer Research (264 citations), Immunology (220 citations) and Molecular Biology (600 citations). Yingqi Liu has collaborated with scholars based in China, Japan and Thailand. Frequent co-authors include Menghuan Li, Zhong Luo, Kaiyong Cai, Yan Hu, Xuan Wang, Yuanyuan Zhao, Chencheng Xue, Lei Shi, Xuemei Yao and Hongli Shan. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.